Rajeev Mantri is the founder and managing director of Navam Capital. See contact routes.
Rajeev Mantri is the founder and managing director of Navam Capital, an India-focused venture capital firm where he leads early-stage investments in deep tech and frontier tech startups since 2008. His investment thesis targets science-driven innovation and IP-backed technologies in sectors including hardware, biotech, green technology, and cleantech, with a focus on the three Ts: team, technology, and total addressable market. Navam closed its maiden fund at Rs 315 crore ($35 million) and plans to back 15–16 startups, though specific check sizes and lead/follow behavior are not publicly detailed. Notable portfolio companies include Vyome Therapeutics, a biopharma venture he co-founded in 2010, and Akamara Biomedicine, where he serves as a director. Mantri is a widely published columnist on technology and venture capital in India, writing for The Wall Street Journal, The New York Times, Mint, and MIT Technology Review. He also co-authored the best-selling book *A New Idea of India: Individual Rights In A Civilisational State* in 2020, reflecting his distinctive viewpoint on India’s economic and civilisational future.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Calcutta Bagh Bazar.
Investors like Rajeev Mantri · Full investor directory · Investor access · Company funding database